Lilly also has another GLP-1 drug in development, called retatrutide, which has shown greater weight loss in trials than any other drug on the market
However, these drugs were all intentionally made to treat type 2 diabetes
Research-based treatment pathways Some individuals explore structured programs that focus on metabolic and peptide-based therapies
GIP: Synergizes with GLP-1 to further reduce appetite, improve fat metabolism, and mitigate side effects
7 Causes of Weight Loss Plateaus on GLP-1 Medications Hitting a weight loss plateau on GLP-1 medications like Semaglutide or Wegovy is common and temporary
Key Benefits (from Clinical Trials) Phase 2 clinical trials have shown promising, dose-dependent results when used alongside diet and exercise: Significant Weight Loss: Participants on the highest dose (12 mg) lost up to 24.2% of their body weight over 48 weeks, a result that surpasses current approved medications like Mounjaro and Wegovy in trial comparisons